Division of Gastroenterology, Tohoku University Graduate School of Medicine.
Department of Health Record Informatics, Tohoku Medical Megabank Organization, Tohoku University.
Tohoku J Exp Med. 2021 Jan;253(1):29-39. doi: 10.1620/tjem.253.29.
In esophageal squamous cell carcinoma (ESCC) comprising 90% of cases with esophageal cancer, endoscopic resection (ER) is recommended for patients with negligible risk of ESCC-related mortality. In fact, a main cause of death in patients underwent ER is not ESCC. We thus aimed to clarify the predictors for early and late mortality among patients underwent ER of ESCC between 2005 and 2018 at our institution. In this retrospective cohort study, we investigated the prognosis and predictors of early and late mortality with the cut-off value of 3 years. We enrolled 407 patients with a median 69 months follow-up. The 5-year overall survival and disease-specific survival, an indicator of ESCC-related mortality, were 83.4% and 98.4%, respectively. In multivariate Cox analyses, Eastern Cooperative Oncology Group performance status (ECOG-PS), consisting of six grades by a patient's level of activity, ≥ 2 was a predictor for early and late morality [hazard ratio (HR), 7.21 (P = 0.007) and 15.62 (P = 0.021), respectively]. Charlson comorbidity index (CCI), which is an index for predicting mortality by comorbid conditions, ≥ 2 was also a predictor for both mortality [HR, 2.97 (P = 0.017) and 1.90 (P = 0.019), respectively]. However, age was a predictor only for late mortality [HR, 3.08 (P = 0.010) in 80-84 years and 8.38 (P < 0.001) in ≥ 85 years]. Considering the predictive ability for early mortality, we propose that ECOG-PS and/or CCI are better indices compared with age in deciding treatment strategy after ER for ESCC.
在占食管癌 90%的食管鳞状细胞癌(ESCC)中,内镜下切除术(ER)推荐用于 ESCC 相关死亡率可忽略不计的患者。事实上,接受 ER 治疗的患者死亡的一个主要原因并不是 ESCC。因此,我们旨在明确本机构在 2005 年至 2018 年期间接受 ER 治疗的 ESCC 患者的早期和晚期死亡率的预测因素。在这项回顾性队列研究中,我们通过 3 年的时间截点来研究预后和早期及晚期死亡率的预测因素。我们共纳入了 407 名患者,中位随访时间为 69 个月。5 年总生存率和疾病特异性生存率(ESCC 相关死亡率的指标)分别为 83.4%和 98.4%。在多变量 Cox 分析中,ECOG-PS(由患者活动水平分为六级)≥2 是早期和晚期死亡率的预测因素[风险比(HR)分别为 7.21(P=0.007)和 15.62(P=0.021)]。Charlson 合并症指数(CCI)(一种通过合并症预测死亡率的指数)≥2 也是两种死亡率的预测因素[HR 分别为 2.97(P=0.017)和 1.90(P=0.019)]。然而,年龄仅与晚期死亡率相关[80-84 岁的 HR 为 3.08(P=0.010),≥85 岁的 HR 为 8.38(P<0.001)]。考虑到早期死亡率的预测能力,我们提出 ECOG-PS 和/或 CCI 是比年龄更好的指标,可用于决定 ESCC 患者 ER 治疗后的治疗策略。